SS Innovations International, Inc. (NASDAQ: SSII) has engaged IBN to support its corporate communications strategy as the company continues to advance its portfolio of surgical robotic technologies. SS Innovations’ product lineup is led by its proprietary SSi Mantra surgical robotic system, which has been used in more than 11,700 procedures worldwide and is complemented by the SSi Mudra robotic instruments, SSi MantrAsana tele-surgeon console and SSi Maya mixed-reality platform.
Under the agreement, IBN will leverage its investor-focused communications network, including InvestorWire and more than 5,000 syndication outlets, newsletters, social media channels and other distribution platforms, to increase awareness of SS Innovations among investors, journalists and the broader market. For more details, see the full press release at https://nnw.fm/Jiyh0.
This engagement comes at a pivotal time for SS Innovations, as the company seeks to expand the global footprint of its cost-effective robotic surgery solutions. The SSi Mantra system, developed with a focus on affordability and accessibility, positions the company to address a significant unmet need in markets where traditional robotic surgery systems are prohibitively expensive. By partnering with IBN, SS Innovations aims to communicate its value proposition more effectively to the investment community and potential partners.
The implications of this announcement are twofold. First, it signals SS Innovations’ commitment to increasing market visibility, which could attract new investors and strategic collaborations. Second, the broader dissemination of information about the SSi Mantra system’s clinical adoption—over 11,700 procedures—underscores the technology’s growing acceptance among surgeons and hospitals. This could accelerate adoption rates and drive revenue growth for the company.
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. For the latest news and updates relating to SSII, visit the company’s newsroom at https://nnw.fm/SSII.
